Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1825 1
1827 1
1845 4
1846 1
1849 1
1855 1
1861 1
1862 1
1864 1
1865 1
1866 1
1867 1
1868 1
1869 2
1870 1
1873 1
1874 1
1878 1
1883 3
1885 1
1887 1
1892 1
1908 1
1909 1
1910 1
1918 1
1921 1
1926 5
1927 1
1928 2
1929 1
1930 1
1931 2
1933 1
1934 6
1935 6
1937 1
1938 2
1939 3
1940 4
1941 2
1942 3
1944 1
1945 6
1946 14
1947 11
1948 7
1949 9
1950 11
1951 12
1952 8
1953 7
1954 8
1955 9
1956 8
1957 3
1958 6
1959 12
1960 15
1961 10
1962 10
1963 13
1964 14
1965 15
1966 23
1967 21
1968 19
1969 20
1970 31
1971 34
1972 27
1973 36
1974 29
1975 40
1976 36
1977 43
1978 33
1979 39
1980 26
1981 32
1982 23
1983 38
1984 43
1985 42
1986 44
1987 50
1988 54
1989 63
1990 49
1991 66
1992 72
1993 82
1994 84
1995 77
1996 80
1997 94
1998 98
1999 113
2000 525
2001 149
2002 181
2003 174
2004 178
2005 192
2006 240
2007 227
2008 261
2009 259
2010 294
2011 309
2012 296
2013 346
2014 478
2015 608
2016 663
2017 729
2018 876
2019 1486
2020 2715
2021 3630
2022 3854
2023 3780
2024 1592

Text availability

Article attribute

Article type

Publication date

Search Results

22,522 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Miranda-Alicea
Page 1
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion.
Leuzzi G, Vasciaveo A, Taglialatela A, Chen X, Firestone TM, Hickman AR, Mao W, Thakar T, Vaitsiankova A, Huang JW, Cuella-Martin R, Hayward SB, Kesner JS, Ghasemzadeh A, Nambiar TS, Ho P, Rialdi A, Hebrard M, Li Y, Gao J, Gopinath S, Adeleke OA, Venters BJ, Drake CG, Baer R, Izar B, Guccione E, Keogh MC, Guerois R, Sun L, Lu C, Califano A, Ciccia A. Leuzzi G, et al. Cell. 2024 Feb 15;187(4):861-881.e32. doi: 10.1016/j.cell.2024.01.008. Epub 2024 Jan 31. Cell. 2024. PMID: 38301646
Filippo Giancotti (1958-2023).
DePinho R, Massagué J, Manji G, Rustgi AK, Izar B. DePinho R, et al. Nat Cancer. 2023 Oct;4(10):1401-1402. doi: 10.1038/s43018-023-00639-3. Nat Cancer. 2023. PMID: 37770653 No abstract available.
A modular master regulator landscape controls cancer transcriptional identity.
Paull EO, Aytes A, Jones SJ, Subramaniam PS, Giorgi FM, Douglass EF, Tagore S, Chu B, Vasciaveo A, Zheng S, Verhaak R, Abate-Shen C, Alvarez MJ, Califano A. Paull EO, et al. Cell. 2021 Jan 21;184(2):334-351.e20. doi: 10.1016/j.cell.2020.11.045. Epub 2021 Jan 11. Cell. 2021. PMID: 33434495 Free PMC article.
Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.
Li Y, Goldberg EM, Chen X, Xu X, McGuire JT, Leuzzi G, Karagiannis D, Tate T, Farhangdoost N, Horth C, Dai E, Li Z, Zhang Z, Izar B, Que J, Ciccia A, Majewski J, Yoon AJ, Ailles L, Mendelsohn CL, Lu C. Li Y, et al. Mol Cell. 2022 Oct 20;82(20):3901-3918.e7. doi: 10.1016/j.molcel.2022.09.007. Epub 2022 Oct 6. Mol Cell. 2022. PMID: 36206767 Free PMC article.
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators.
Obradovic A, Ager C, Turunen M, Nirschl T, Khosravi-Maharlooei M, Iuga A, Jackson CM, Yegnasubramanian S, Tomassoni L, Fernandez EC, McCann P, Rogava M, DeMarzo AM, Kochel CM, Allaf M, Bivalacqua T, Lim M, Realubit R, Karan C, Drake CG, Califano A. Obradovic A, et al. Cancer Cell. 2023 May 8;41(5):933-949.e11. doi: 10.1016/j.ccell.2023.04.003. Epub 2023 Apr 27. Cancer Cell. 2023. PMID: 37116491 Free PMC article.
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer.
Hawley JE, Obradovic AZ, Dallos MC, Lim EA, Runcie K, Ager CR, McKiernan J, Anderson CB, Decastro GJ, Weintraub J, Virk R, Lowy I, Hu J, Chaimowitz MG, Guo XV, Zhang Y, Haffner MC, Worley J, Stein MN, Califano A, Drake CG. Hawley JE, et al. Cancer Cell. 2023 Nov 13;41(11):1972-1988.e5. doi: 10.1016/j.ccell.2023.10.006. Epub 2023 Nov 2. Cancer Cell. 2023. PMID: 37922910 Free article.
Scalable co-sequencing of RNA and DNA from individual nuclei.
Olsen TR, Talla P, Furnari J, Bruce JN, Canoll P, Zha S, Sims PA. Olsen TR, et al. bioRxiv [Preprint]. 2023 Feb 10:2023.02.09.527940. doi: 10.1101/2023.02.09.527940. bioRxiv. 2023. PMID: 36798358 Free PMC article. Preprint.
Nothing changes if nothing changes.
Salna M, Anderson BR, Bacha E, Kurlansky P. Salna M, et al. Interact Cardiovasc Thorac Surg. 2022 Aug 3;35(3):ivac217. doi: 10.1093/icvts/ivac217. Interact Cardiovasc Thorac Surg. 2022. PMID: 35980295 Free PMC article. No abstract available.
22,522 results
You have reached the last available page of results. Please see the User Guide for more information.